JSM Veterinary Medicine and Research

Archive Articles

Article Image 1

Perioperative Chemotherapy (CAPOX 3X3) in Resectable Non-Metastatic Gastric Adenocarcinomas: What is the Benefit on Survival?

Although the incidence of gastric cancer has been declining spontaneously and steadily for over 50 years, stomach cancer remains common. The World Health Organization’s 2020 annual report indicates a global incidence of gastric cancer estimated at 1,089,103 new cases per year, representing 5.6% of all cancers, with a mortality rate of approximately 768,793 deaths per year, accounting for 7.7% of all cancer deaths and ranking gastric cancer third in cancer mortality worldwide.

Kheloufi M1*, Boudiaf Z1, Bouzid C1, Chibane A1, Boutekedjiret IH1, Cherchar K1, Hattou Z1, Bachiri L2, Elghazali A2, Rezoug F2, Benmoussa D2, Ait Kaci H3, Oukal M4 and Bentabak K1


Submit a Manuscript